We are live on ! Find out more
BCM

Boone Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$89.3M
Cap. Flow
-$79.8M
Cap. Flow %
-26.92%
Top 10 Hldgs %
89.74%
Holding
19
New
2
Increased
5
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
BHVN icon
Biohaven
BHVN
+$16.9M
2
PRGO icon
Perrigo
PRGO
+$15M
3
GNW icon
Genworth Financial
GNW
+$11M
4
MOH icon
Molina Healthcare
MOH
+$3.13M
5
OFIX icon
Orthofix Medical
OFIX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 76.58%
2 Financials 23.42%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNM icon
1
Unum
UNM
$13.7B
$58.7M 19.8%
803,865
-160,305
-17% -$11.1M
GMED icon
2
Globus Medical
GMED
$10.7B
$47M 15.86%
568,465
-83,245
-13% -$6.57M
PRGO icon
3
Perrigo
PRGO
$1.41B
$26.3M 8.87%
1,022,369
+570,148
+126% +$15M
MIRM icon
4
Mirum Pharmaceuticals
MIRM
$6.55B
$24.1M 8.12%
581,843
+38,000
+7% +$1.58M
MOH icon
5
Molina Healthcare
MOH
$10.2B
$23.8M 8.03%
81,842
+10,138
+14% +$3.13M
CI icon
6
Cigna
CI
$75.1B
$23.7M 8%
85,861
-46,065
-35% -$14.7M
OFIX icon
7
Orthofix Medical
OFIX
$467M
$18.5M 6.23%
1,057,313
+126,806
+14% +$2.2M
PNTG icon
8
Pennant Group
PNTG
$1.4B
$17M 5.74%
641,255
BHVN icon
9
Biohaven
BHVN
$2.03B
$13.5M 4.55%
+361,420
New +$16.9M
IDYA icon
10
IDEAYA Biosciences
IDYA
$3.44B
$13.5M 4.55%
524,868
-6,762
-1% -$191K
IQV icon
11
IQVIA
IQV
$38.3B
$11.2M 3.79%
57,141
-10,441
-15% -$2.2M
GNW icon
12
Genworth Financial
GNW
$3.78B
$10.7M 3.62%
+1,536,612
New +$11M
VKTX icon
13
Viking Therapeutics
VKTX
$3.72B
$8.44M 2.85%
209,853
+16,964
+9% +$967K
AMPH icon
14
Amphastar Pharmaceuticals
AMPH
$868M
-316,556
Closed -$15.4M
BAX icon
15
Baxter International
BAX
$13.5B
-441,821
Closed -$16.8M
CERT icon
16
Certara
CERT
$1.23B
-541,830
Closed -$6.34M
CHE icon
17
Chemed
CHE
$7.06B
-39,422
Closed -$23.7M
DHR icon
18
Danaher
DHR
$137B
-61,327
Closed -$17.1M
BERY
19
DELISTED
Berry Global Group, Inc.
BERY
-266,785
Closed -$16.7M

Similar funds

Boone Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boone Capital Management held 19 positions worth $296M, down 23% from $386M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Boone Capital Management withdrew a net $79.8M in Q4 2024, closing 6 positions and reducing 5 holdings. Its most notable exit was Chemed, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 81% a quarter earlier, followed by Financials and Materials.

Against the trend, Boone Capital Management opened a new position in Biohaven worth $13.5M.

  • Boone Capital Management's largest Q4 2024 buy was Biohaven: 361,420 shares worth $13.5M.
  • Boone Capital Management added most to Perrigo in Q4 2024, an estimated $15M increase.
  • Boone Capital Management's biggest Q4 2024 reduction was Cigna, cutting an estimated $14.7M.
  • Boone Capital Management fully exited Chemed in Q4 2024, selling an estimated $23.7M.
  • Boone Capital Management's ten largest holdings make up 90% of its $296M portfolio in Q4 2024.
  • Boone Capital Management opened 2 new positions and closed 6 in Q4 2024.
  • Boone Capital Management's portfolio value fell 23% quarter-over-quarter to $296M.

Based on Boone Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.